Histone deacetylase (HDAC) inhibitors down-regulate endothelial lineage commitment of umbilical cord blood derived endothelial progenitor cells

International Journal of Molecular Sciences

Volumn 13, Issue 11, 2012, Pages 15074-15085

  Iordache, Florin ^a   Buzila, Cosmin ^a   Constantinescu, Andrei ^a   Andrei, Eugen ^a   Maniu, Horia ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Acetylation; Differentiation; Endothelial progenitor cells; Histone deacetylases

Indexed keywords

ANGIOPOIETIN RECEPTOR; BUTYRIC ACID; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COMPLEMENT COMPONENT C3B RECEPTOR; ENDOGLIN; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; INTERCELLULAR ADHESION MOLECULE 1; STEM CELL FACTOR RECEPTOR; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRICHOSTATIN A; VALPROIC ACID; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; HISTONE DEACETYLASE INHIBITOR;

ACETYLATION; ARTICLE; CD133 GENE; CELL ASSAY; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOTILITY; CELL PROLIFERATION; CHEMOKINE RECEPTOR CXCR4 GENE; CONTROLLED STUDY; CYTOTOXICITY; DEACETYLATION; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIE GENE; UMBILICAL CORD BLOOD; VASCULAR ENDOTHELIAL CADHERIN GENE; WOUND HEALING; CELL MOTION; CYTOLOGY; DRUG EFFECTS; ENZYME ACTIVATION; FETUS BLOOD; GENETICS; HUMAN; IMMUNOPHENOTYPING; METABOLISM;

CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL PROGENITOR CELLS; ENZYME ACTIVATION; FETAL BLOOD; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HUMANS; IMMUNOPHENOTYPING; TELOMERASE;

EID: 84870695090     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131115074     Document Type: Article

References (34)

1. Jenuwein, T.; Allis C.D. Translating the Histone Code. Science 2001, 293, 1074-1080.
2. Li, B.; Carey, M.; Workman, J.L. The Role of Chromatin during Transcription. Cell 2007, 128, 707-719.
3. Lee, J.S.; Smith, E.; Shilatifard, A. The Language of Histone Crosstalk. Cell 2010, 142, 682-685.
4. Vincent, A.; Seuningen, V.I. Epigenetics, stem cells and epithelial cell fate. Differentiation 2009, 78, 99-107.
5. Robertson, K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6, 597-610.
6. Flier, L.G.; Clevers, H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol. 2009, 71, 241-260.
7. Gan, Y.; Shen, Y.H.; Wang, J.; Wang, X.; Utama, B.; Wang, J.; Wang, X.L. Role of Histone Deacetylation in Cell-specific Expression of Endothelial Nitric-oxide Synthase. J. Biol. Chem. 2005, 280, 16467-16475.
8. Mariadason, J.M. HDACs and HDAC inhibitors in colon cancer. Epigenetics 2008, 3, 28-37.
9. Witt, O.; Deubzer, H.E.; Milde, T.; Oehme, I. HDAC family: What are the cancer relevant targets? Cancer Lett. 2009, 277, 8-21.
10. Monneret, C. Histone deacetylase inhibitors. Eur. J. Med. Chem. 2005, 401-413.
11. Lupu, M.; Khalil, M.; Andrei, E.; Iordache, F.; Pfannkuche, K.; Neef, K.; Georgescu, A.; Buzila, C.; Brockmeier, K.; Maniu, H.; et al. Integration Properties of Wharton's Jelly-derived Novel Mesenchymal Stem Cells into Ventricular Slices of Murine Hearts. Cell. Physiol. Biochem. 2011, 28, 63-76.
12. Lupu, M.; Khalil, M.; Iordache, F.; Andrei, E.; Pfannkuche, K.; Spitkovsky, D.; Baumgartner, S.; Rubach, M.; AbdelRazik, H.; Buzila, C.; et al. Direct Contact of Umbilical Cord Blood Endothelial Progenitors with Living Cardiac Tissue is a Requirement for Vascular Tube-like Structures Formation. J. Cell. Mol. Med. 2011, 15, 1914-1926.
13. Iordache, F.; Iordache, C.; Pop, A.; Lupu, M.; Andrei, E.; Buzila, C.; Maniu, H. Effects of plant lectin and extracts on adhesion molecules of endothelial progenitors Cent. Eur. J. Biol. 2011, 6, 330-341.
14. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275, 964-967.
15. Zhang, L.; Yang, R.; Han, Z.C. Transplantation of umbilical cord blood derived endothelial progenitor cells: A promising method of therapeutic revascularisation. Eur. J. Haematol. 2006, 76, 1-8.
16. Wada, T.; Kikuchi, J.; Nishimura, N.; Shimizu, R.; Kitamura, T.; Furukawa, Y. Expression levels of histone deacetylases determine the cell fate of hematopoietic progenitors. J. Biol. Chem. 2009, 284, 30673-30683.
17. Ohtani, K.; Dimmeler, S. Epigenetic regulation of cardiovascular differentiation. Cardiovasc. Res. 2011, 90, 404-441.
18. Dzau, V.J.; Gnecchi, M.; Pachori, A.S.; Morello, F.; Melo, L.G. Therapeutic Potential of Endothelial Progenitor Cells in Cardiovascular Diseases. Hypertension 2005, 46, 7-18.
19. Cian, A.; Lacroix, L.; Douarre, C.; Temime-Smaali, N.; Trentesaux, C.; Riou, J.F.; Mergny, J.L. Targeting telomeres and telomerase. Biochimie 2008, 90, 131-155.
20. Murasawa, S.; Llevadot, J.; Silver, M.; Isner, J.M.; Losordo, D.W.; Asahara, T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 2002, 106, 1133-1139.
21. Yang, J.; Chang, E.; Cherry, A.M. Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 1999, 274, 26141-26148.
22. Yoder, M.C. Defining human endothelial progenitor cells. J. Thromb. Haemost. 2009, 7, 49-52.
23. Duda, D.G.; Cohen, K.S.; Scadden, D.T.; Jain, R.K. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat. Protocol. 2007, 2, 805-810.
24. Rössig, L.; Urbich, C.; Brühl, T.; Dernbach, E.; Heeschen, C.; Chavakis, E.; Sasaki, K.; Aicher, D.; Diehl, F.; Seeger, F.; et al. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J. Exp. Med., 2005, 201, 1825-1835.
25. Xi, R.; Xie, T. Stem Cell Self-Renewal Controlled by Chromatin Remodeling Factors. Science 2005, 310, 1487-1489.
26. Kretsovali, A.; Hadjimichael, C.; Charmpilas, N. Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming. Stem Cells Int. 2012, doi:10.1155/2012/184154.
27. Shi G.; Gao F.; Jin Y. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells. J. Cell. Physiol. 2011, 226, 3190-3196.
28. Burba, I.; Colombo, G.I.; Staszewsky, L.I.; de Simone, M.; Devanna, P.; Nanni, S.; Avitabile, D.; Molla, F.; Cosentino, S.; Russo, I.; et al. Histone Deacetylase Inhibition Enhances Self Renewal and Cardioprotection by Human Cord Blood-Derived CD34+ Cells. PLoS One 2011, 6, e22158.
29. Mottet, D.; Bellahcène, A.; Pirotte, S.; Waltregny, D.; Deroanne, C.; Lamour, V.; Lidereau, R.; Castronovo, V. Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circ. Res. 2007, 101, 1237-1246.
30. Lee, J.H.; Hart, S.; Skalnik, D.G. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 2004, 38, 32-38.
31. Lagger, G.; O'Carroll, D.; Rembold, M.; Khier, H.; Tischler, J.; Weitzer, G.; Schuettengruber, B.; Hauser, C.; Brunmeir, R.; Jenuwein, T.; et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 2002, 21, 2672-2681.
32. Deroanne, C.F.; Bonjean, K.; Servotte, S.; Devy, L.; Colige, A.; Clausse, N.; Blacher, S.; Verdin, E.; Foidart, J.M.; Nusgens, B.V.; et al. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene 2002, 21, 427-436.
33. Matouk, C.C.; Marsden, P.A. Epigenetic Regulation of Vascular Endothelial Gene Expression Circ. Res. 2008, 102, 873-887.
34. Fischer, A.; Sananbenesi, F.; Wang, X.; Dobbin, M.; Tsai, L.H. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007, 447, 178-182.